Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Midcervical vagotomy precludes respiratory response to novel anti-inflammatory and anti-tumour drug arvanil in rats.
Journal: European journal of pharmacology 20100915
Title: Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
Journal: European journal of pharmacology 20100901
Title: Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats.
Journal: Life sciences 20080718
Title: TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080611
Title: Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Journal: The European journal of neuroscience 20070501
Title: Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells.
Journal: Immunology letters 20070415
Title: Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
Journal: European journal of pharmacology 20060928
Title: Iodinated N-acylvanillamines: potential 'multiple-target' anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels.
Journal: Molecular pharmacology 20060401
Title: Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.
Journal: Journal of neuroimmunology 20060201
Title: Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Journal: Neurobiology of disease 20051101
Title: Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.
Journal: British journal of pharmacology 20050901
Title: Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
Journal: Brain research 20050719
Title: Membrane receptor probes: solid-phase synthesis of biotin-Asp-PEG-arvanil derivatives.
Journal: Organic letters 20050428
Title: Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
Journal: European journal of pharmacology 20050418
Title: Cloning and pharmacological characterization of mouse TRPV1.
Journal: Neuroscience letters 20041103
Title: The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway.
Journal: British journal of pharmacology 20031101
Title: Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20030515
Title: Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells.
Journal: Biochemical pharmacology 20030215
Title: N-Acylvanillamides: development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor.
Journal: Journal of medicinal chemistry 20020815
Title: Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
Journal: European journal of pharmacology 20020329
Title: A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
Journal: The Journal of pharmacology and experimental therapeutics 20020301
Title: Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Journal: The Biochemical journal 20010815
Title: Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor 'hybrid' ligands.
Journal: Biochemical and biophysical research communications 20010223
Title: Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Journal: British journal of pharmacology 20010201
